Computational Chemistry Intern - 2027
Genesis Molecular AI
Summary
Genesis Molecular AI is bringing together a world-class computational team to build the industry's fastest and most accurate small molecule property predictions by combining machine learning and physics-based methods. We are looking for early-career scientists who develop and apply computational chemistry and physics methods, increasingly with AI in the loop, to push forward our challenging drug discovery programs.
Job description
Computational Chemistry Intern, Summer 2027
Genesis Molecular AI is bringing together a world-class computational team to build the industry's fastest and most accurate small molecule property predictions by combining machine learning and physics-based methods. We are looking for early-career scientists who develop and apply computational chemistry and physics methods, increasingly with AI in the loop, to push forward our challenging drug discovery programs.
You will
- Work with a dedicated mentor on a focused research project that matches your interests and expertise and addresses a key challenge in our internal and partnered drug discovery programs.
- Develop and refine computational chemistry and physics methods. Potential project areas include quantum chemistry (DFT and wavefunction methods, QM/MM, torsional and conformational energetics, protonation and tautomer states), free energy simulations (relative and absolute binding free energies), and enhanced sampling (metadynamics, replica exchange, adaptive sampling).
- Collaborate with our machine learning team on molecular modeling and property prediction. Potential projects include machine-learned interatomic potentials (MLIPs) and hybrid ML/MM simulations, learned molecular representations, learned collective variables for enhanced sampling, generative models of conformational ensembles, protein-ligand co-folding and binding affinity prediction, and ADME property prediction.
- Work closely with our computer-aided drug discovery scientists and medicinal chemists to benchmark methods on real program data, test predictions prospectively, and integrate successful improvements into our drug discovery platform.
You are
- A PhD student with a proven track record of applying or developing computational chemistry and physics methods. Exceptional MS or advanced undergraduate students with substantial research experience are also encouraged to apply.
- Experienced in one or more areas of computational chemistry: quantum chemistry, free energy methods, enhanced sampling, molecular dynamics, or machine learning for molecular systems. Depth in one area matters more than breadth across all of them.
- Passionate about building methods that solve real problems, and rigorous about testing assumptions and validating results.
- A skilled programmer, preferably in Python, who can quickly turn research ideas into working code and assess the accuracy and reliability of the resulting methods.
- Experienced using AI coding agents to accelerate your work, with the scientific and engineering judgment to verify generated code, debug subtle failures, and recognize when results are physically wrong.
Requirements
- PhD student with a proven track record of applying or developing computational chemistry and physics methods
- Exceptional MS or advanced undergraduate students with substantial research experience also encouraged to apply
- Experienced in one or more areas of computational chemistry: quantum chemistry, free energy methods, enhanced sampling, molecular dynamics, or machine learning for molecular systems
- Passionate about building methods that solve real problems and rigorous about testing assumptions and validating results
- Skilled programmer, preferably in Python
- Experienced using AI coding agents with judgment to verify generated code and debug failures
Benefits
- One-on-One Mentor
- End-of-Summer Presentation
Company overview
Genesis Molecular AI is a pioneering biotechnology company headquartered in Burlingame, California, with additional facilities in San Diego and New York. The company specializes in developing foundation models for molecular artificial intelligence to revolutionize drug design and development. Genesis operates at the intersection of AI and biotechnology, utilizing its proprietary GEMS (Genesis Exploration of Molecular Space) platform to accelerate small molecule drug discovery. The platform integrates advanced AI algorithms with physics-based modeling to generate and optimize drug molecules, including the breakthrough Pearl diffusion model for protein-ligand structure prediction. Genesis has raised over $300 million in funding from prominent investors including Andreessen Horowitz, NVIDIA's NVentures, Fidelity, and BlackRock. The company maintains an internal drug pipeline targeting high-value therapeutic areas and has established strategic collaborations with major pharmaceutical companies like Gilead and Incyte. With a team of 51-200 employees, Genesis Molecular AI represents a leading force in AI-driven drug discovery, combining cutting-edge computational approaches with traditional pharmaceutical development to address complex biological targets and create novel therapeutics.